A61K 9/7038
Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive
Official title: {Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer}
A61K9/7038 (Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive) appears on 1,513 US grants and 2,073 published applications in this corpus.
Search patents in A61K- Granted patents
- 1,513
- Published applications
- 2,073
- Assignees
- 690
- Inventors
- 3,001
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 2 | 0 |
| 1978 | 0 | 0 |
| 1979 | 0 | 0 |
| 1980 | 3 | 0 |
| 1981 | 1 | 0 |
| 1982 | 1 | 0 |
| 1983 | 3 | 0 |
| 1984 | 8 | 0 |
| 1985 | 3 | 0 |
| 1986 | 9 | 0 |
| 1987 | 9 | 0 |
| 1988 | 13 | 0 |
| 1989 | 31 | 0 |
| 1990 | 23 | 0 |
| 1991 | 27 | 0 |
| 1992 | 30 | 0 |
| 1993 | 39 | 0 |
| 1994 | 32 | 0 |
| 1995 | 29 | 0 |
| 1996 | 35 | 0 |
| 1997 | 50 | 0 |
| 1998 | 57 | 0 |
| 1999 | 56 | 0 |
| 2000 | 39 | 0 |
| 2001 | 42 | 20 |
| 2002 | 36 | 45 |
| 2003 | 36 | 78 |
| 2004 | 29 | 108 |
| 2005 | 15 | 82 |
| 2006 | 30 | 71 |
| 2007 | 16 | 79 |
| 2008 | 14 | 67 |
| 2009 | 11 | 90 |
| 2010 | 25 | 77 |
| 2011 | 34 | 103 |
| 2012 | 47 | 78 |
| 2013 | 46 | 81 |
| 2014 | 63 | 121 |
| 2015 | 65 | 84 |
| 2016 | 65 | 97 |
| 2017 | 50 | 86 |
| 2018 | 43 | 122 |
| 2019 | 58 | 88 |
| 2020 | 53 | 98 |
| 2021 | 57 | 91 |
| 2022 | 38 | 85 |
| 2023 | 43 | 65 |
| 2024 | 35 | 61 |
| 2025 | 40 | 54 |
| 2026 | 21 | 42 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Patch for alleviating or treating symptoms of neurodegenerative disease29 Sep 2026US 12,746,232 B2Nobelpharma AB
- Transdermal patch of a portable ultrasound-generating system for improved delivery of therapeutic agents and associated methods of treatment8 Sep 2026US 12,728,102 B2NanoVibronix Inc
- Transdermal delivery of dextromethorphan8 Sep 2026US 12,728,127 B2Shinkei Therapeutics, Inc.
- Treatment of 22Q11.2 deletion syndrome with cannabidiol25 Aug 2026US 12,714,718 B2Harmony Biosciences Management, Inc.
- Compositions of matter and pharmaceutical compositions28 Jul 2026US 12,691,098 B2Atai Therapeutics, Inc.
- Systems and methods for transderman patch delivery8 Oct 2026US 2026/0306421 A1
- Hydrogel patch for wound healing promotion or scar minimization1 Oct 2026US 2026/0294851 A1Ck Regeon Inc.
- Systems and methods for delivery of drugs and other substances comprising deep eutectic solvents24 Sep 2026US 2026/0283948 A1Novilla Pharmaceuticals, Inc.
- Transdermal patches for administering compounds and body adornment24 Sep 2026US 2026/0283976 A1Barriere, Inc.
- Transdermal systems having polyisobutylene and methods of making and using them17 Sep 2026US 2026/0272847 A1Viatris GmbH & Co. KG
Most cited
By later US patents
- Transdermal and trans-membrane delivery of drugs515US 5,023,252 AConrex Pharmaceutical Corporation · 1991
- Solubility parameter based drug delivery system and method for altering drug saturation concentration448US 5,656,286 ANoven Pharmaceuticals, Inc. · 1997
- Transdermal administration of fentanyl and device therefor411US 4,588,580 AAlza Corporation · 1986
- Medical bandage344US 3,996,934 AAlza Corporation · 1976
- Tamper-resistant oral opioid agonist formulations343US 6,696,088 B2Euro-Celtique S. A. · 2004